Shield & Care Pharmaceuticals Pvt Ltd
Gliclazide (40mg) + Metformin (500mg)
Gliclashield-M 40 Tablet is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Tablet
Gliclashield-M 40 Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Gliclashield-M 40 Tablet is to be taken with food.
No common side effects listed.
It is unsafe to consume alcohol with Gliclashield-M 40 Tablet.
Gliclashield-M 40 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Gliclashield-M 40 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Gliclashield-M 40 Tablet is a combination of two antidiabetic medicines: Gliclazide and Metformin.
Monitor your blood sugar level regularly while you are taking this medicine. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting, and stomach pain as Gliclashield-M 40 Tablet may cause a rare but serious condition called lactic acidosis.
Gliclashield-M 40 Tablet contains two active ingredients: Gliclazide and Metformin. This medication is used to manage type 2 diabetes mellitus (DM) by improving blood glucose levels in adults when combined with proper diet and exercise. Gliclazide helps increase insulin release from the pancreas, while Metformin reduces glucose production in the liver and enhances insulin sensitivity.
Like many medications, Gliclashield-M 40 Tablet can cause some common side effects. These include hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. In rare cases, it may also lead to more serious side effects such as lactic acidosis.
Yes, Gliclashield-M 40 Tablet can cause hypoglycemia. This is a low blood sugar that may lead to various symptoms such as dizziness, confusion, shakiness, and increased hunger. It's important to monitor your blood glucose levels regularly, especially if you are experiencing these symptoms.
Gliclashield-M 40 Tablet contains the active ingredients Gliclazide and Metformin. It's a combination medication used to treat type 2 diabetes mellitus (DM) by improving blood glucose levels in adults when combined with proper diet and exercise. Gliclazide helps increase insulin release from the pancreas, while Metformin reduces glucose production in the liver.
Gliclashield-M 40 Tablet can cause various side effects. These include hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections.
Yes, Gliclashield-M 40 Tablet can potentially cause lactic acidosis. Lactic acidosis is a rare but serious condition that involves an excessive buildup of lactic acid in the body.